Platelet-Activating Factor-Induced Inflammation in Obesity: A Two-Sided Coin of Protection and Risk

Area of Science:

• Biochemistry
• Cell Biology
• Physiology

Background:

• Obesity is a global health issue linked to chronic inflammation and metabolic dysfunction.
• Acute inflammation aids healthy adipose tissue remodeling, while chronic inflammation contributes to metabolic disorders.
• Platelet-activating factor (PAF) is a key mediator in inflammatory processes and pathophysiological conditions.

Purpose of the Study:

• To explore the role of PAF in fat accumulation and obesity.
• To propose a biochemical mechanism for PAF's dual role in healthy and obese adipose tissue.
• To investigate PAF's potential involvement in epigenetic mechanisms related to 'obesity memory'.

Main Methods:

• Review of experimental data from cell cultures, animal models, and human studies.
• Analysis of biochemical pathways involved in PAF signaling in adipose tissue.
• Examination of epigenetic mechanisms potentially linking PAF to obesity.

Main Results:

• PAF exhibits a dual role in adipose tissue, influencing both healthy remodeling and obesity-associated inflammation.
• Evidence suggests PAF's involvement in epigenetic mechanisms contributing to 'obesity memory'.
• Natural PAF modulators and lifestyle interventions (Mediterranean diet, exercise) can promote functional adipose tissue and prevent obesity by controlling PAF levels.

Conclusions:

• PAF is a critical factor in adipose tissue function and obesity development.
• Lifestyle modifications and natural compounds can modulate PAF activity for obesity prevention.
• Pharmacological PAF inhibitors may help manage metabolic dysfunction in obesity-related inflammation.